Mesocortical dopamine system modulates mechanical nociceptive responses recorded in the rat prefrontal cortex

BMC Neuroscience

Volumn 14, Issue , 2013, Pages

  Sogabe, Shoichi ^a   Yagasaki, Yuki ^a   Onozawa, Kitaro ^b   Kawakami, Yoriko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

ACC; D2R; Dopamine; Pain; Parkinson disease; PFC; VTA

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; APOMORPHINE; DOPAMINE RECEPTOR; OXIDOPAMINE; QUINPIROLE; SULPIRIDE;

ANESTHESIA LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTROCORTICOGRAPHY; MALE; MECHANICAL STIMULATION; MEDIAL FOREBRAIN BUNDLE; MICROINJECTION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PREFRONTAL CORTEX; PRESSURE; RAT; VENTRAL TEGMENTUM;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ACTION POTENTIALS; ANALGESICS, NON-NARCOTIC; ANIMALS; BIOPHYSICS; DOPAMINE; DOPAMINE AGENTS; ELECTRIC STIMULATION; FUNCTIONAL LATERALITY; MALE; MEDIAL FOREBRAIN BUNDLE; NEURAL PATHWAYS; NOCICEPTIVE PAIN; PHYSICAL STIMULATION; PREFRONTAL CORTEX; RATS; RATS, WISTAR; VENTRAL TEGMENTAL AREA;

EID: 84879810095     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-14-65     Document Type: Article

References (50)

1. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I. Imaging how attention modulates pain in humans using functional MRI. Brain 2002, 125(Pt 2):310-319.
2. Rainville P, Duncan G, Price D, Carrier B, Bushnell M. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997, 277(5328):968-971. 10.1126/science.277.5328.968, 9252330.
3. Singer T, Seymour B, O'Doherty J, Kaube H, Dolan RJ, Frith CD. Empathy for pain involves the affective but not sensory components of pain. Science 2004, 303(5661):1157-1162. 10.1126/science.1093535, 14976305.
4. Sikes RW, Vogt BA. Nociceptive neurons in area 24 of rabbit cingulate cortex. J Neurophysiol 1992, 68(5):1720-1732.
5. Zhang R, Tomida M, Katayama Y, Kawakami Y. Response durations encode nociceptive stimulus intensity in the rat medial prefrontal cortex. Neuroscience 2004, 125(3):777-785. 10.1016/j.neuroscience.2004.01.055, 15099691.
6. Johansen JP, Fields HL, Manning BH. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A 2001, 98(14):8077-8082. 10.1073/pnas.141218998, 35470, 11416168.
7. Etkin A, Egner T, Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci 2011, 15(2):85-93. 10.1016/j.tics.2010.11.004, 3035157, 21167765.
8. Onozawa K, Yagasaki Y, Izawa Y, Abe H, Kawakami Y. Amygdala-prefrontal pathways and the dopamine system affect nociceptive responses in the prefrontal cortex. BMC Neurosci 2011, 12:115. 10.1186/1471-2202-12-115, 3228703, 22085449.
9. Carr DB, Sesack SR. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 2000, 38(2):114-123. 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R, 11018785.
10. Potvin S, Grignon S, Marchand S. Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse 2009, 63(5):390-402. 10.1002/syn.20616, 19173266.
11. Nogueira L, Lavin A. Strong somatic stimulation differentially regulates the firing properties of prefrontal cortex neurons. Brain Res 2010, 1351:57-63. 2952415, 20624375.
12. Beiske A, Loge J, Ronningen A, Svensson E. Pain in Parkinson's disease: Prevalence and characteristics. Pain 2009, 141(1-2):173-177.
13. Chaudhuri K, Healy D, Schapira A. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5(3):235-245. 10.1016/S1474-4422(06)70373-8, 16488379.
14. Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 2008, 65(9):1191-1194. 10.1001/archneurol.2008.2, 18779422.
15. Lopez-Avila A, Coffeen U, Ortega-Legaspi J, del Angel R, Pellicer F. Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex. Pain 2004, 111(1-2):136-143.
16. Tassorelli C, Armentero MT, Greco R, Fancellu R, Sandrini G, Nappi G, Blandini F. Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease. Brain Res 2007, 1176:53-61.
17. Chudler EH, Lu Y. Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine. Brain Res 2008, 1213:41-47. 2483947, 18456244.
18. Saade NE, Atweh SF, Bahuth NB, Jabbur SJ. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res 1997, 751:1-12. 10.1016/S0006-8993(96)01164-X, 9098562.
19. Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A 2006, 103(8):2938-2942. 10.1073/pnas.0511159103, 1413839, 16477003.
20. Seguela P, Watkins KC, Descarries L. Ultrastructural features of dopamine axon terminals in the anteromedial and the suprarhinal cortex of adult rat. Brain Res 1988, 442:11-22. 10.1016/0006-8993(88)91427-8, 3359247.
21. Yokofujita J, Oda S, Igarashi H, Sato F, Kuroda M. Synaptic characteristics between cortical cells in the rat prefrontal cortex and axon terminals from the ventral tegmental area that utilize different neurotransmitters. Int J Neurosci 2008, 118(10):1443-1459. 10.1080/00207450701870253, 18788028.
22. Vogt BA, Sikes RW, Vogt LJ. From Anterior cingulate cortex and the medial pain system. Neurobiology of cingulate cortex and limbic thalamus 1993, 313-344. Boston: Birkhauser, Vogt BA, Gabriel M.
23. Seamans J, Yang C. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004, 74(1):1-58. 10.1016/j.pneurobio.2004.05.006, 15381316.
24. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 2002, 125(Pt 3):584-594.
25. Vorobyov VV, Schibaev NV, Morelli M, Carta AR. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease. Brain Res 2003, 972:177-185. 10.1016/S0006-8993(03)02528-9, 12711091.
26. Garris PA, Wightman RM. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 1994, 14(1):442-450.
27. Westerink BH, Enrico P, Feimann J, De Vries JB. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther 1998, 285(1):143-154.
28. Godbout R, Mantz J, Pirot S, Glowinski J, Thierry AM. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization. J Pharmacol Exp Ther 1991, 258(2):728-738.
29. Otani S, Auclair N, Desce J, Roisin M, Crepel F. Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J Neurosci 1999, 19(22):9788-9802.
30. Lavin A, Nogueira L, Lapish CC, Wightman RM, Phillips PE, Seamans JK. Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J Neurosci 2005, 25(20):5013-5023. 10.1523/JNEUROSCI.0557-05.2005, 15901782.
31. Devoto P, Flore G, Saba P, Castelli MP, Piras AP, Luesu W, Viaggi MC, Ennas MG, Gessa GL. 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex. J Neurosci Res 2008, 86(7):1647-1658. 10.1002/jnr.21611, 18189323.
32. Goto Y, Otani S, Grace AA. The Yin and Yang of dopamine release: a new perspective. Neuropharmacology 2007, 53(5):583-587. 10.1016/j.neuropharm.2007.07.007, 2078202, 17709119.
33. Parfitt KD, Gratton A, Bickford-Wimer PC. Electrophysiological effects of selective D1 and D2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats. J Pharmacol Exp Ther 1990, 254(2):539-545.
34. Pirot S, Godbout R, Mantz J, Tassin J, Glowinski J, Thierry A. Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience 1992, 49(4):857-865. 10.1016/0306-4522(92)90362-6, 1436485.
35. Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1993, 33:281-307. 10.1146/annurev.pa.33.040193.001433, 8494342.
36. Vincent SL, Khan Y, Benes FM. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex. J Neurosci 1993, 13(6):2551-2564.
37. Vincent SL, Khan Y, Benes FM. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 1995, 19(2):112-120. 10.1002/syn.890190207, 7725240.
38. Neal A. From Neurotransmitter receptors. Fundamental Neuroscience 2008, 181-204. London: Academic Press, Squire LR, Berg D, Bloom FE, 3.
39. Li YC, Liu G, Hu JL, Gao WJ, Huang YQ. Dopamine D1 receptor-mediated enhancement of NMDA receptor trafficking requires rapid PKC-dependent synaptic insertion in the prefrontal neurons. J Neurochem 2010, 114(1):62-73.
40. Gurden H, Takita M, Jay TM. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J Neurosci 2000, 20(22):RC106.
41. Santana N, Mengod G, Artigas F. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 2009, 19(4):849-860.
42. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 2007, 10(3):376-384. 10.1038/nn1846, 17277774.
43. Zahrt J, Taylor JR, Mathew RG, Arnsten AF. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 1997, 17(21):8528-8535.
44. Nakamura H, Katayama Y, Kawakami Y. Hippocampal CA1/subiculum-prefrontal cortical pathways induce plastic changes of nociceptive responses in cingulate and prelimbic areas. BMC Neurosci 2010, 11:100. 10.1186/1471-2202-11-100, 2936438, 20716327.
45. Singer T, Seymour B, O'Doherty JP, Stephan KE, Dolan RJ, Frith CD. Empathic neural responses are modulated by the perceived fairness of others. Nature 2006, 439(7075):466-469. 10.1038/nature04271, 2636868, 16421576.
46. Wolf ME, Mangiavacchi S, Sun X. Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann N Y Acad Sci 2003, 1003:241-249. 10.1196/annals.1300.015, 14684450.
47. Cervero F, Handwerker HO, Laird JM. Prolonged noxious mechanical stimulation of the rat's tail: responses and encoding properties of dorsal horn neurons. J Physiol 1988, 404:419-436. 1190833, 3253436.
48. Nagata T, Suzuki H, Zhang R, Ozaki M, Kawakami Y. Mechanical stimulation activates small fiber mediated nociceptive responses in the nucleus gigantocellularis. Exp Brain Res 2003, 149(4):505-511.
49. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates 1998, San Diego: Academic Press, 4.
50. Gurden H, Tassin JP, Jay TM. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation. Neuroscience 1999, 94(4):1019-1027. 10.1016/S0306-4522(99)00395-4, 10625044.